Logo image of MXL

MAXLINEAR INC (MXL) Stock Fundamental Analysis

NASDAQ:MXL - US57776J1007 - Common Stock

16.35 USD
+1.2 (+7.92%)
Last: 8/22/2025, 8:25:52 PM
16.28 USD
-0.07 (-0.43%)
After Hours: 8/22/2025, 8:25:52 PM
Fundamental Rating

2

Taking everything into account, MXL scores 2 out of 10 in our fundamental rating. MXL was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of MXL have multiple concerns. MXL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MXL had negative earnings in the past year.
MXL had a negative operating cash flow in the past year.
In multiple years MXL reported negative net income over the last 5 years.
MXL had a positive operating cash flow in 4 of the past 5 years.
MXL Yearly Net Income VS EBIT VS OCF VS FCFMXL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With a Return On Assets value of -24.30%, MXL is not doing good in the industry: 83.64% of the companies in the same industry are doing better.
MXL's Return On Equity of -42.99% is on the low side compared to the rest of the industry. MXL is outperformed by 84.55% of its industry peers.
Industry RankSector Rank
ROA -24.3%
ROE -42.99%
ROIC N/A
ROA(3y)-8.18%
ROA(5y)-6.04%
ROE(3y)-13.22%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
MXL Yearly ROA, ROE, ROICMXL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

MXL has a Gross Margin of 55.73%. This is in the better half of the industry: MXL outperforms 77.27% of its industry peers.
MXL's Gross Margin has been stable in the last couple of years.
MXL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.93%
GM growth 5Y0.43%
MXL Yearly Profit, Operating, Gross MarginsMXL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

MXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MXL has been increased compared to 1 year ago.
The number of shares outstanding for MXL has been increased compared to 5 years ago.
MXL has a worse debt/assets ratio than last year.
MXL Yearly Shares OutstandingMXL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MXL Yearly Total Debt VS Total AssetsMXL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

MXL has an Altman-Z score of 1.65. This is a bad value and indicates that MXL is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of MXL (1.65) is worse than 66.36% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that MXL is not too dependend on debt financing.
MXL has a Debt to Equity ratio of 0.25. This is comparable to the rest of the industry: MXL outperforms 41.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 1.65
ROIC/WACCN/A
WACC11.49%
MXL Yearly LT Debt VS Equity VS FCFMXL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

MXL has a Current Ratio of 1.55. This is a normal value and indicates that MXL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.55, MXL is doing worse than 82.73% of the companies in the same industry.
MXL has a Quick Ratio of 1.14. This is a normal value and indicates that MXL is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MXL (1.14) is worse than 83.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.14
MXL Yearly Current Assets VS Current LiabilitesMXL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

MXL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.63%.
Looking at the last year, MXL shows a very negative growth in Revenue. The Revenue has decreased by -15.65% in the last year.
The Revenue has been growing slightly by 2.59% on average over the past years.
EPS 1Y (TTM)-11.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%108%
Revenue 1Y (TTM)-15.65%
Revenue growth 3Y-26.07%
Revenue growth 5Y2.59%
Sales Q2Q%18.29%

3.2 Future

MXL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.78% yearly.
MXL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.45% yearly.
EPS Next Y129.3%
EPS Next 2Y69.42%
EPS Next 3Y47.79%
EPS Next 5Y35.78%
Revenue Next Year28.33%
Revenue Next 2Y22.75%
Revenue Next 3Y18.6%
Revenue Next 5Y16.45%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MXL Yearly Revenue VS EstimatesMXL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
MXL Yearly EPS VS EstimatesMXL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

MXL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 20.65, MXL is valued on the expensive side.
MXL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MXL is cheaper than 70.91% of the companies in the same industry.
MXL is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 35.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 20.65
MXL Price Earnings VS Forward Price EarningsMXL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MXL Per share dataMXL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MXL's earnings are expected to grow with 47.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y69.42%
EPS Next 3Y47.79%

More info and screens

0

5. Dividend

5.1 Amount

MXL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAXLINEAR INC

NASDAQ:MXL (8/22/2025, 8:25:52 PM)

After market: 16.28 -0.07 (-0.43%)

16.35

+1.2 (+7.92%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-21 2025-10-21/amc
Inst Owners83.61%
Inst Owner Change0.81%
Ins Owners6.58%
Ins Owner Change1.96%
Market Cap1.42B
Analysts72
Price Target20.25 (23.85%)
Short Float %6.5%
Short Ratio3.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.44%
Min EPS beat(2)-3.14%
Max EPS beat(2)10.01%
EPS beat(4)2
Avg EPS beat(4)6.63%
Min EPS beat(4)-10.24%
Max EPS beat(4)29.89%
EPS beat(8)4
Avg EPS beat(8)-1.98%
EPS beat(12)7
Avg EPS beat(12)-0.9%
EPS beat(16)11
Avg EPS beat(16)1.17%
Revenue beat(2)1
Avg Revenue beat(2)1.33%
Min Revenue beat(2)-0.01%
Max Revenue beat(2)2.67%
Revenue beat(4)3
Avg Revenue beat(4)1.18%
Min Revenue beat(4)-0.01%
Max Revenue beat(4)2.67%
Revenue beat(8)4
Avg Revenue beat(8)-1.03%
Revenue beat(12)4
Avg Revenue beat(12)-1.31%
Revenue beat(16)7
Avg Revenue beat(16)-0.89%
PT rev (1m)31.89%
PT rev (3m)31.89%
EPS NQ rev (1m)1.71%
EPS NQ rev (3m)-16.78%
EPS NY rev (1m)-3.65%
EPS NY rev (3m)-3.65%
Revenue NQ rev (1m)7.75%
Revenue NQ rev (3m)7.46%
Revenue NY rev (1m)3.81%
Revenue NY rev (3m)3.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.65
P/S 3.77
P/FCF N/A
P/OCF N/A
P/B 2.92
P/tB 12.34
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)0.79
Fwd EY4.84%
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS4.34
BVpS5.61
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.3%
ROE -42.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.73%
FCFM N/A
ROA(3y)-8.18%
ROA(5y)-6.04%
ROE(3y)-13.22%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.93%
GM growth 5Y0.43%
F-Score2
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 39.63%
Cap/Sales 4.85%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.14
Altman-Z 1.65
F-Score2
WACC11.49%
ROIC/WACCN/A
Cap/Depr(3y)51.53%
Cap/Depr(5y)53.82%
Cap/Sales(3y)5.32%
Cap/Sales(5y)5.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%108%
EPS Next Y129.3%
EPS Next 2Y69.42%
EPS Next 3Y47.79%
EPS Next 5Y35.78%
Revenue 1Y (TTM)-15.65%
Revenue growth 3Y-26.07%
Revenue growth 5Y2.59%
Sales Q2Q%18.29%
Revenue Next Year28.33%
Revenue Next 2Y22.75%
Revenue Next 3Y18.6%
Revenue Next 5Y16.45%
EBIT growth 1Y4.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year199.09%
EBIT Next 3Y61.25%
EBIT Next 5YN/A
FCF growth 1Y-154.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-129.18%
OCF growth 3YN/A
OCF growth 5YN/A